| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLX | Common Stock | +Grant/Award | $0 | +170 | +21.96% | $0.00 | 944 | Jun 30, 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLX | Deferred Stock Units | +Grant/Award | $0 | +58 | +0.61% | $0.00 | 9,560 | May 7, 2021 | Common Stock | 58 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Receipt of Common Stock in lieu of receipt of director's fees pursuant to the Independent Directors' Stock-Based Compensation Plan. |
| F2 | 1-for-1 |
| F3 | Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. |
| F4 | The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |